Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease

被引:31
作者
Green, AJE [1 ]
机构
[1] Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
cerebrospinal fluid; encephalopathy; prion disease;
D O I
10.1042/bst0300382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transmissible spongiform encephalopathies include human diseases such as Creutzfeldt-Jakob disease (CJD) and kuru as well as animal diseases such as scrapie and bovine spongiform encephalopathy (BSE). The emergence of variant CJD, which is causally related to BSE, has generated much interest in the development of rapid and sensitive diagnostic tests for the pre-mortem diagnosis of CJD. In 1986 two proteins were detected in the cerebrospinal fluid (CSF) of patients with sporadic CJD. These proteins were later demonstrated to be members of the 14-3-3 family, and tests for the detection of CSF 14-3-3 were developed. A number of studies have shown that the detection of CSF 14-3-3 is an accurate test for sporadic CJD, although the results with variant CJD are less promising.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 53 条
  • [1] 14-3-3 PROTEINS - A HIGHLY CONSERVED, WIDESPREAD FAMILY OF EUKARYOTIC PROTEINS
    AITKEN, A
    COLLINGE, DB
    VANHEUSDEN, BPH
    ISOBE, T
    ROSEBOOM, PH
    ROSENFELD, G
    SOLL, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (12) : 498 - 501
  • [2] BALDWIN MA, 1993, PRION DIS HUMANS ANI, P380
  • [3] 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Beaudry, P
    Cohen, P
    Brandel, JP
    Delasnerie-Lauprêtre, N
    Richard, S
    Launay, JM
    Laplanche, JL
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) : 40 - 46
  • [4] BERNOULLI C, 1977, LANCET, V1, P478
  • [5] HUMAN 14-3-3 PROTEIN - RADIOIMMUNOASSAY, TISSUE DISTRIBUTION, AND CEREBROSPINAL-FLUID LEVELS IN PATIENTS WITH NEUROLOGICAL DISORDERS
    BOSTON, PF
    JACKSON, P
    THOMPSON, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) : 1475 - 1482
  • [6] Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates
    Brandel, JP
    Delasnerie-Lauprêtre, N
    Laplanche, JL
    Hauw, JJ
    Alpérovitch, A
    [J]. NEUROLOGY, 2000, 54 (05) : 1095 - 1099
  • [7] Brandel JP, 2001, ANN NEUROL, V49, P257, DOI 10.1002/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO
  • [8] 2-X
  • [9] HUMAN SPONGIFORM ENCEPHALOPATHY - THE NATIONAL-INSTITUTES-OF-HEALTH SERIES OF 300 CASES OF EXPERIMENTALLY TRANSMITTED DISEASE
    BROWN, P
    GIBBS, CJ
    RODGERSJOHNSON, P
    ASHER, DM
    SULIMA, MP
    BACOTE, A
    GOLDFARB, LG
    GAJDUSEK, DC
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (05) : 513 - 529
  • [10] POTENTIAL EPIDEMIC OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN GROWTH-HORMONE THERAPY
    BROWN, P
    GAJDUSEK, DC
    GIBBS, CJ
    ASHER, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) : 728 - 731